Showing 1541-1550 of 5798 results for "".
2018 Therapeutics and Device Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-2018-therapeutics-and-device-highlights/18374/2018 saw new approvals and clearances for acne, impetigo, psoriasis, and skin cancer from Ortho Dermatologics, Sun Pharma, Cutanea, and more. Plus, updates for Restylane, new devices from BTL, Cutera, and others.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sLaser Innovations on the Horizon
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-innovations-on-the-horizon/18534/Jill Waibel, MD discusses advances in lasers and what's on the horizon. She shares insights on a new and improved pulsed dye laser plus RF; fractional applications being investigated for scars, vitiligo, wrinkles, and more; plus devices for vaginal rejuvenation.The Menassaince
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-menassaince/18722/Men are an increasingly important demographic in aesthetics today, Steven Dayan, MD tells Dermtube host Joel Cohen, MD. Unlike their female counterparts, men tend to prefer one-and-done procedures and often seek treatment after hours, he says.Eyes Have It: Bloodless Blephs and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/eyes-have-it-bloodless-blephs-and-more/18728/Demand for treatments around the eye continue to grow; patients want big results but little downtime. Dr. Niamtu discusses his "bloodless bleph" and other uses for fillers and toxins.PsO Many Options: The Expanded Psoriasis Landscape
https://practicaldermatology.com/topics/psoriasis/pso-many-options-the-expanded-psoriasis-landscape/18749/By Jeffrey Weinberg, MD and Seemal R. Desai, MDWith many new therapies coming out in oral, topical, and biologic forms, there are fewer unmet needs in psoriasis management now than ever before. Dr. Weinberg navigates the therapeutic landscape.ICD-10: When the Rubber Meets the Road
https://practicaldermatology.com/topics/practice-management/icd-10-when-the-rubber-meets-the-road/18632/When plans to move to ICD-10 were first announced, providers expressed concerns about potential logistical concerns with the new coding system. However, now that the new system is in regular use, Leon Kircik, MD said health claim denial rates have been lower than expected and the transition has beenTreatment Considerations for Hyperpigmentation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/treatment-considerations-for-hyperpigmentation/18830/Seemal R. Desai, MD and Marta I. Rendon, MD discuss their treatment protocols for hyperpigmentation—from prescriptions and cosmeceuticals to lasers and peels. Noting that hyperpigmentation is a chronic, life-long condition, they emphasize the importance of vehicle consideration in enhancing efficacyElectronic Brachytherapy: Understanding the Technology and Identifying Appropriate Use
https://practicaldermatology.com/topics/practice-management/electronic-brachytherapy-understanding-the-technology-and-identifying-appropriate-use/21148/The following information is for dermatology practices concerning Appropriate Use Criteria (AUC) for Electronic Brachytherapy.Clinical Insights on Management of Comorbidities in the Psoriasis Patient
https://practicaldermatology.com/topics/psoriasis/clinical-insights-on-management-of-comorbidities-in-the-psoriasis-patient/21375/As psoriasis is associated with an increasing number of comorbidities, clinicians discuss their approach to management focused on the whole patient.